DKSH Technology Strengthens its Korean Business with the Acquisition of MDxK
DKSH has announced today that it signed an agreement to acquire MDxK, a well-established South Korean provider of advanced scientific solut ...
BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024
March 26, 2025, 7am CET BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious ...